Plain-English translation of NCT07610473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 trial testing a medication called as an add-on treatment for people with major depression who are already on depression medication. The study will compare to a placebo (inactive pill) to see if this medication can help reduce depression symptoms and how well it is tolerated. About 118 adults will participate.
Many people with depression continue to struggle with their symptoms even while taking medication. This trial is testing whether adding this medication to existing depression treatment can help improve outcomes for patients who haven't found relief with their current medication alone.
You likely qualify if…
You likely don't qualify if…
You will visit the study site several times over 8 weeks. At the start, you'll have physical and neurological exams, blood and urine tests, and assessments of your depression symptoms. You'll then be randomly assigned to receive either the new medication or a placebo to take alongside your current depression medication. Throughout the 8 weeks, you'll have repeated check-ins, blood tests to measure how your body absorbs the medication, and assessments to track any changes in your depression symptoms and how well you tolerate the treatment.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States